Search

everythinglearnresearchcommunity

for

Search:↓

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

Corticosteroids and topical irritants are used to treat alopecia areata.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

JAK inhibitors may help treat both alopecia areata and vitiligo, but more research is needed.

Blocking LFA-1 prevents hair loss in mice.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Inflammation in rheumatoid arthritis increases steroid activation in cells, reducing inflammation.

New, effective treatments for alopecia areata require innovative approaches targeting the immune system.

MicroRNAs are important for skin development and diseases and could be used for treatment and diagnosis.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

Topical contact sensitizers can treat certain skin conditions by changing the immune response.

Higher monocyte counts predict less effective adalimumab treatment in hidradenitis suppurativa patients.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Relatives of lupus patients show signs of immune system activity but not full-blown lupus.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Entospletinib effectively prevents eye and skin GVHD in mice.

Different γδ T cell types have unique roles in causing alopecia areata.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

Targeting specific T cells may help treat alopecia areata.